Study Assessing the Effect of 3-week Treatment With One of Three Oral Doses of Quinagolide
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
Women included in this study are undergoing controlled ovarian hyperstimulation for assisted
reproductive technologies (ART) and present with signs of moderate risk of developing OHSS.